Engineering the perfect (bacterial) cancer therapy

被引：611
作者：
Forbes, Neil S. [1 ]
机构：
[1] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA
来源：
NATURE REVIEWS CANCER | 2010年 / 10卷 / 11期
基金：
美国国家卫生研究院;
关键词：
ATTENUATED SALMONELLA-TYPHIMURIUM; ENTERICA-SEROVAR-TYPHIMURIUM; MURINE TUMOR-MODELS; ENZYME-PRODRUG THERAPY; ESCHERICHIA-COLI NISSLE-1917; POSITRON-EMISSION-TOMOGRAPHY; PROTEIN EXPRESSION THERAPY; GENE-THERAPY; IN-VIVO; TARGETING SALMONELLA;
D O I：
10.1038/nrc2934
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Bacterial therapies possess many unique mechanisms for treating cancer that are unachievable with standard methods. Bacteria can specifically target tumours, actively penetrate tissue, are easily detected and can controllably induce cytotoxicity. Over the past decade, Salmonella, Clostridium and other genera have been shown to control tumour growth and promote survival in animal models. In this Innovation article I propose that synthetic biology techniques can be used to solve many of the key challenges that are associated with bacterial therapies, such as toxicity, stability and efficiency, and can be used to tune their beneficial features, allowing the engineering of 'perfect' cancer therapies.
引用
收藏
页码：784 / 793
页数：10
相关论文
共 139 条
  • [21] Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agents
    Dang, LH
    Bettegowda, H
    Agrawal, N
    Cheong, I
    Huso, D
    Fil, P
    Loganzos, F
    Greenbergell, L
    Barkoczy, J
    Pettit, GR
    Smith, AB
    Gurulingappa, H
    Khall, S
    Parmigiani, G
    Kill, KW
    Zhou, SB
    [J]. CANCER BIOLOGY & THERAPY, 2004, 3 (03) : 326 - 337
  • [22] Oral somatic transgene vaccination using attenuated S-typhimurium
    Darji, A
    Guzman, CA
    Gerstel, B
    Wachholz, P
    Timmis, KN
    Wehland, J
    Chakraborty, T
    Weiss, S
    [J]. CELL, 1997, 91 (06) : 765 - 775
  • [23] Non-invasive 19F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours
    Dresselaers, T
    Theys, J
    Nuyts, S
    Wouters, B
    de Bruijn, E
    Anné, J
    Lambin, P
    Van Hecke, P
    Landuyt, W
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (09) : 1796 - 1801
  • [24] Efficacy of gene therapy-delivered cytosine deaminase is determined by enzymatic activity but not expression
    Dubois, L.
    Dresselaers, T.
    Landuyt, W.
    Paesmans, K.
    Mengesha, A.
    Wouters, B. G.
    Van Hecke, P.
    Theys, J.
    Lambin, P.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 96 (05) : 758 - 761
  • [25] ENGELBART K, 1964, CANCER RES, V24, P239
  • [26] Liver and circulating NK1.1+CD3- cells are increased in infection with attenuated Salmonella typhimurium and are associated with reduced tumor in murine liver cancer
    Feltis, BA
    Miller, JS
    Sahar, DA
    Kim, AS
    Saltzman, DA
    Leonard, AS
    Wells, CL
    Sielaff, TD
    [J]. JOURNAL OF SURGICAL RESEARCH, 2002, 107 (01) : 101 - 107
  • [27] Feng Keke, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P389
  • [28] Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B
    Fensterle, J.
    Bergmann, B.
    Yone, C. L. R. P.
    Hotz, C.
    Meyer, S. R.
    Spreng, S.
    Goebel, W.
    Rapp, U. R.
    Gentschev, I.
    [J]. CANCER GENE THERAPY, 2008, 15 (02) : 85 - 93
  • [29] Forbes NS, 2003, CANCER RES, V63, P5188
  • [30] Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy
    Friedlos, Frank
    Lehouritis, Panos
    Ogilvie, Lesley
    Hedley, Douglas
    Davies, Lawrence
    Bermudes, David
    King, Ivan
    Martin, Jan
    Marais, Richard
    Springer, Caroline J.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4259 - 4266
12345678910